In Finland the vaccine has not salvaged the child from mors from a flu

In the end of last week in Finland from flu A/H1N1 the two-year-old child who has been vaccinated earlier has died, writes eurolab.ua.

According to service of public health services of Helsinki, the child was included into bunch of risk and the engrafting has been made two weeks ago. However in some days he was ill with a pork flu and has been hospitalised. Treated the patient in intensive care unit, but efforts of physicians have appeared vain, reports TSN.

The pork flu has reached in Finland of scales of epidemy. On all country 2940 cases of disease are confirmed by this virus, but actually disease cases a pork flu some tens thousand are.

As is known, during a flu epidemic in Ukraine 85 cases of disease are officially confirmed by virus A/H1N1 only, 16 infested have died. At the same time all 300 persons have died of a flu and ORVI from the extremity of October in the country almost. Physicians suppose, that actually sick of a pork flu it is much more, than is fixed in official to the statistican.

<!–

–>

if you used New N95 respirator from Safe Life

Safe Life Corp., an innovative antimicrobial company dedicated to developing novel technologies that prevent the spread of infection and disease, announced today the availability of the Safe Life A400 Series N95 Respirator with Antimicrobial Protection. Unlike traditional N95 respirators, the A400 is a comfortable, breathable respirator with the added protection of an active antimicrobial based on iodine, which has a nearly 200-year track record for being effective against a broad spectrum of microorganisms.

As the H1N1 influenza virus continues to spread around the world, the need for N95 respirators for healthcare workers and other occupational users is more critical than ever. Last month, the Centers for Disease Control and Prevention (CDC) reinforced its existing guidelines on respiratory protection by recommending the use of fit-tested, N95 respirators for healthcare personnel who are in close contact with patients with suspected or confirmed 2009 H1N1 influenza. Other global health organizations that have publicly supported N95 usage include the Institute of Medicine and the Ontario Ministry of Health.

According to Richard Jaffe, chairman and CEO of Safe Life, the A400 represents a significant technology advancement that addresses the major challenges healthcare workers and other occupational users have long faced when wearing N95 respirators. "In the past 20 years, little has changed in respirator design, which means healthcare workers and other occupational users have been forced to choose between the comfort and breathability of a surgical mask and the filtration power of an N95 respirator," he said. "Now, with the A400, which looks and feels like a surgical mask yet has the full protection of a respirator, workers no longer have to make compromises when it comes to comfort, safety and patient care."

Among the first healthcare providers to equip its employees with the new Safe Life N95 Respirator with Antimicrobial Protection is Scripps Health, a $2 billion, nonprofit community health system based in San Diego. To ensure proper protection during the H1N1 pandemic, Scripps is providing Safe Life’s A400 Series respirator to healthcare staff in high-risk settings at all of its five acute-care hospital campuses as well as 19 outpatient centers and clinics.

"The health and safety of Scripps Health employees and patients are top priorities," said Chris Van Gorder, president and CEO of Scripps Health. "The availability of this new product enables us to maintain an ample supply of N95 respirators throughout the flu season and also reinforces an overarching commitment to workplace safety by providing our employees with a respirator that can be worn easily for an entire shift."

SOURCE Safe Life Corp.